Mirum Pharmaceuticals annual revenue
2020
2021
2022
2023
2024
2025
Mirum Pharmaceuticals Revenue Growth & History (MIRM)
Mirum Pharmaceuticals reported $521.3M in revenue for fiscal 2025, an increase of 54.74% from the previous fiscal year.
View full Mirum Pharmaceuticals company overviewMirum Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $521.3M | $184.4M | +54.74% |
| 2024 | 2024-12-31 | $336.9M | $150.5M | +80.76% |
| 2023 | 2023-12-31 | $186.4M | $109.3M | +141.85% |
| 2022 | 2022-12-31 | $77.1M | $57.9M | +302.66% |
| 2021 | 2021-12-31 | $19.1M | $19.1M | — |
| 2020 | 2020-12-31 | $0 | — | — |
Mirum Pharmaceuticals quarterly revenue
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $176.2M | $48.5M | +37.92% |
| Q1 2026 | 2026-03-31 | $159.9M | $48.3M | +43.28% |
| Q4 2025 | 2025-12-31 | $148.9M | $49.5M | +49.81% |
| Q3 2025 | 2025-09-30 | $133.0M | $42.6M | +47.17% |
| Q2 2025 | 2025-06-30 | $127.8M | $49.9M | +64.09% |
| Q1 2025 | 2025-03-31 | $111.6M | $42.4M | +61.20% |
| Q4 2024 | 2024-12-31 | $99.4M | $29.9M | +42.93% |
| Q3 2024 | 2024-09-30 | $90.4M | $42.7M | +89.37% |
| Q2 2024 | 2024-06-30 | $77.9M | $40.4M | +107.68% |
| Q1 2024 | 2024-03-31 | $69.2M | $37.6M | +119.07% |
| Q4 2023 | 2023-12-31 | $69.6M | $41.6M | +149.24% |
| Q3 2023 | 2023-09-30 | $47.7M | $28.9M | +154.13% |
| Q2 2023 | 2023-06-30 | $37.5M | $20.0M | +114.46% |
| Q1 2023 | 2023-03-31 | $31.6M | $18.7M | +145.10% |
| Q4 2022 | 2022-12-31 | $27.9M | $24.8M | +789.29% |
| Q3 2022 | 2022-09-30 | $18.8M | $13.8M | +275.60% |
| Q2 2022 | 2022-06-30 | $17.5M | $6.5M | +58.95% |
| Q1 2022 | 2022-03-31 | $12.9M | $12.9M | — |
| Q4 2021 | 2021-12-31 | $3.1M | — | — |
| Q3 2021 | 2021-09-30 | $5.0M | $5.0M | — |
| Q2 2021 | 2021-06-30 | $11.0M | $11.0M | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
Mirum Pharmaceuticals revenue growth trends
Mirum Pharmaceuticals's latest reported quarter, Q2 2026, generated $176.2M in revenue, an increase of 37.92% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Mirum Pharmaceuticals source filings ↗Community posts
Mirum’s hepatitis-delta drug succeeds in Phase 3 AZURE-1
Mirum Pharmaceuticals ($MIRM) said brelovitug met the primary endpoint in the Phase 3 portion of AZURE-1, which enrolled 153 treatment-naive patients with chronic hepatitis delta. At 24 weeks, the combined viral-response and liver-enzyme-no ...
